The Market Fieldbook

Confirming your account

Your account is being prepared. You will be redirected securely in a moment.

Company Observatory

PGNY

Progyny, Inc.

Healthcare · Medical - Healthcare Information Services

Overall research band Above average
Quality Above average
Valuation Above average
Balance sheet Exceptional
Market confirmation Mixed

One-minute company read

What this report can tell you now

What the company does

Progyny, Inc. is a benefits management company that provides specialized fertility and family-building solutions to employers across the United States. Its main offerings include a unique fertility benefits plan design, personalized member support, and access to a curated network of fertility specialists. Progyny also offers Progyny Rx, a comprehensive pharmacy benefits solution that supplies members with necessary fertility medications. Additionally, the company supports employer-sponsored reimbursement programs for surrogacy and adoption. Progyny generates revenue by delivering these services to employers, who in turn offer them as benefits to their employees.

The current research profile is Market-Leading Quality, with strong market confirmation. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

Business quality is the strongest visible dimension. Check valuation before treating that strength as an investment conclusion.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

  • Read the latest filing or company update.
  • Check the financial period behind each metric.
  • Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC15.2%Model input; read with the evidence status and period context.
Operating margin7.5%Model input; read with the evidence status and period context.
Revenue CAGR · 4 years26.7%Model input; read with the evidence status and period context.
FCF margin14.3%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.
Evidence detailSee exact inputs, source context, and model-aware metrics.
HistoryReview score and research changes over time.
MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.